Do antiepileptic drugs differ in suppressing interictal epileptiform activity in children?

M H Libenson1, B Caravale

  • 1Department of Pediatrics, the Division of Pediatric Neurology, Floating Hospital for Children at New England Medical Center, Boston, MA 02111, USA.

Pediatric Neurology
|April 13, 2001
PubMed

Insights

Valproate (VPA) and carbamazepine (CBZ) demonstrate superior suppression of interictal epileptiform activity compared to phenobarbital (PHB) in children. This finding highlights differences in drug efficacy for managing epilepsy beyond seizure control.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology
  • Epileptology

Background:

  • Antiepileptic drugs (AEDs) aim to suppress seizures and may also reduce interictal epileptiform activity.
  • Comparative efficacy of phenobarbital (PHB), carbamazepine (CBZ), and valproate (VPA) in suppressing interictal epileptiform activity in pediatric patients remains unclear.

Purpose of the Study:

  • To compare the rates of suppression of interictal epileptiform activity by PHB, CBZ, and VPA in children.
  • To determine if AEDs differ in their ability to clear epileptiform discharges on electroencephalograms (EEGs).

Main Methods:

  • Retrospective analysis of 213 paired EEGs from pediatric patients before and after initiation of PHB, CBZ, or VPA.
  • Assessment of interictal epileptiform activity clearance in the second EEG tracing following AED introduction.
  • Subanalysis based on sleep state and type of discharge (focal vs. generalized).

Main Results:

  • Overall suppression rates were 22% for PHB, 33% for CBZ, and 46% for VPA (P=0.005 for VPA vs. PHB).
  • In sleep-state EEGs, suppression rates were 30% for PHB, 40% for CBZ, and 50% for VPA (P=0.005 for PHB vs. VPA).
  • Valproate and carbamazepine showed greater efficacy in suppressing both focal and generalized epileptiform activity compared to phenobarbital.

Conclusions:

  • Valproate and, to a lesser extent, carbamazepine are more effective than phenobarbital in suppressing interictal epileptiform activity in children.
  • These findings suggest distinct mechanisms or potencies among these AEDs regarding EEG discharge suppression.
  • The choice of AED may influence not only seizure control but also the normalization of EEG epileptiform activity.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...